Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Scandinavian ChemoTech

3.85 SEK

0.00 %

Less than 1K followers

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Scandinavian ChemoTech

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue1.52.06.62.53.83.32.612.3
EBITDA-2.7-2.5-10.7-2.1-4.1-0.6-1.6-4.5
EBIT-3.2-3.1-12.8-2.6-4.6-1.1-2.1-6.5
EBIT-%-212.0 %-150.0 %-194.8 %-104.0 %-119.3 %-31.9 %-80.9 %-52.6 %
Profit before taxes-3.2-3.6-13.7-3.3-0.9-1.3-2.5-8.1
Net income-3.2-3.2-13.7-3.3-0.9-1.3-2.5-8.1
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.